ZADITEN 1 mg, hard capsule 60 capsules, CIP 3400932303502
Active ingredients: Ketotifen fumarate, KETOTIFÈNE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule60 capsules, CIP 3400932303502orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZADITEN 1 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 60 gélule(s)
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Aug 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68070293CIP73230350CIP133400932303502Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KETOTIFÈNE (FUMARATE DE)gélule | 1,38 mg · une gélule | SA |
| KETOTIFÈNE BASEgélule | 1 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.